RNA, U7 small nuclear 81 pseudogene (RNU7-81P)

RNU7-81P is categorized as a **pseudogene** of the U7 small nuclear RNA gene family. The canonical U7 small nuclear RNA (snRNA) is an integral part of the U7 small nuclear ribonucleoprotein (snRNP) complex, which is essential for the 3’ end processing of histone pre-mRNA[4][5]. The functional U7 snRNA binds to histone downstream elements and plays a crucial role in histone transcript maturation, distinct from typical pre-mRNA processing pathways[4][5]. However, **RNU7-81P** specifically refers to a pseudogene copy, meaning it does not encode a functional RNA or protein product. Such pseudogenes arise from gene duplication or retrotransposition and typically do not give rise to active RNA molecules or affect cellular processes. There is no evidence linking RNU7-81P to any known biological function, disease, or pharmacological targeting. For context, mutations in the functional U7 snRNA gene (RNU7-1) have been linked to Aicardi-Goutières syndrome and defective histone RNA processing[2][3], but pseudogene forms like RNU7-81P do not perform these roles and are not considered biologically active or clinically relevant targets. Notes: - There is no evidence that RNU7-81P is a functional gene or a therapeutic target; it is a non-functional remnant (pseudogene) of the U7 snRNA gene family[6]. - If a biologically active or disease-relevant target is needed, refer to the **RNA, U7 small nuclear 1** (RNU7-1) gene, not RNU7-81P[2][3]. - The entry is considered **incorrect for drug discovery or therapeutic relevance**, as it is a pseudogene, not an active target. Summary: RNU7-81P is a pseudogene and not a functional molecular target. It is unrelated to disease, drug mechanism, or biomarker status, and therefore is **not suitable or correct as a therapeutic target entry**. For active biology, only the functional U7 snRNA (such as RNU7-1) is of relevance[2][3][5].

Other names

U7.81RNU7-81P